Table: OncoTherapy Science -Q1 group results

OncoTherapy Science

08/08/2025 09:00

Aug 8 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2025        Jun 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            201 mln             100 mln                    
                (+100.1 pct)         (-32.0 pct)                  
  Operating     loss 303 mln        loss 290 mln                  
  Recurring     loss 313 mln        loss 302 mln                  
  Net           loss 314 mln        loss 302 mln                  
  EPS           loss 1.13 yen       loss 1.30 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T